Literature DB >> 8840850

Effect of atrial fibrillation on atrial refractoriness in humans.

E G Daoud1, F Bogun, R Goyal, M Harvey, K C Man, S A Strickberger, F Morady.   

Abstract

BACKGROUND: The acute effect of atrial fibrillation (AF) on the atrial effective refractory period (ERP) in humans is unknown. METHODS AND
RESULTS: In 20 patients without structural heart disease, the atrial ERP was measured before and after pacing-induced AF at drive cycle lengths of 350 and 500 ms. Immediately after spontaneous AF conversion, the post-AF ERP was measured. The pre-AF ERPs at 350 and 500 ms were 206 +/- 23 and 216 +/- 17 ms, respectively. The time to spontaneous conversion of AF was 7.3 +/- 1.9 minutes. The first post-AF ERPs at drive cycle lengths of 350 and 500 ms were 175 +/- 30 ms (P < .0001 versus pre-AF) and 191 +/- 30 ms (P < .0001 versus pre-AF), respectively. The post-AF ERP returned to the pre-AF ERP value after a mean of 8.4 +/- 0.3 minutes. In 15 patients, during the determination of the post-AF ERP, secondary episodes of AF lasting 1 +/- 1.5 minutes were reinduced 6 +/- 3 times per patient. There was a significant inverse logarithmic relationship between the time to reinduction of AF and the duration of secondary episodes of AF (P < .0001, r = 5).
CONCLUSIONS: In humans, several minutes of induced AF is sufficient to shorten the ERP for up to approximately 8 minutes. The temporal recovery of the ERP is reflected in progressively shorter episodes of reinduced AF. These data imply that AF transiently shortens the atrial wavelength and suggest a mechanism by which AF may perpetuate itself.

Entities:  

Mesh:

Year:  1996        PMID: 8840850     DOI: 10.1161/01.cir.94.7.1600

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  38 in total

1.  Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study.

Authors:  E Bertaglia; D D'Este; A Zanocco; F Zerbo; P Pascotto
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

2.  Acute pressure overload cardiac arrhythmias are dependent on the presence of myocardial tissue catecholamines.

Authors:  A J Drake-Holland; M I Noble; M J Lab
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

Review 3.  Chronic and paroxysmal atrial fibrillation: course, prognosis, and stroke risk.

Authors:  T E Cuddy
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 4.  Catheter mapping of spontaneous and induced atrial fibrillation in man.

Authors:  S Saksena; A Shankar; A Prakash; R B Krol
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

5.  Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.

Authors:  H F Tse; C P Lau; G M Ayers
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

6.  Atrial electrical remodeling by rapid pacing in the isolated rabbit heart: effects of Ca++ and K+ channel blockade.

Authors:  M A Wood; D Caponi; A M Sykes; E J Wenger
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

7.  Non-invasive characterisation of coronary lesion morphology by multi-slice computed tomography: a promising new technology for risk stratification of patients with coronary artery disease.

Authors:  S Schroeder; A F Kopp; A Baumbach; A Kuettner; C Georg; B Ohnesorge; C Herdeg; C D Claussen; K R Karsch
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

8.  P-wave signal-averaged electrocardiogram predicts atrial fibrillation after coronary artery bypass grafting.

Authors:  Paolo Caravelli; Marco De Carlo; Giuseppe Musumeci; Giuseppe Tartarini; Gherardo Gherarducci; Uberto Bortolotti; Massimo A Mariani; Mario Mariani
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

9.  Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil.

Authors:  C-J A Lindholm; O Fredholm; S-J Möller; N Edvardsson; T Kronvall; T Pettersson; V Firsovaite; A Roijer; C J Meurling; P G Platonov; S B Olsson
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

10.  Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).

Authors:  Maryse Palardy; Anique Ducharme; Stanley Nattel; Jean-Claude Tardif; Michel White; Normand Racine; Karine Tétreault; Farida Dabouz; Mario Talajic; Denis Roy
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.